Keyphrases
N-terminal Domain
100%
Oncofetal
100%
Cisplatin Resistance
100%
Chimeric Construct
100%
Lectin Complement Pathway
100%
Glycosaminoglycans
100%
Bladder Cancer
100%
Complement Factor H
100%
Alternative Complement Pathway
100%
Oversulfated Chondroitin Sulfate
100%
Genetic Engineering
100%
Muscle-invasive Bladder Cancer
88%
Novel Therapeutics
61%
Alternative Pathway Activation
50%
Alternative Pathway
50%
Collectin
50%
Lectin Pathway
50%
Mannose-binding Lectin
50%
Inflammation
50%
Ficolin
50%
Complement Cascade
50%
Classical Pathway
50%
Human Serum
50%
Functional Assay
50%
Inhibition Potential
50%
Lectin
50%
Human Factors
50%
Pattern Recognition Receptors
50%
Selective Targeting
50%
EC50
50%
Complement Inhibition
50%
Central Regulator
50%
Complement Activation
50%
Solid Phase
50%
Associated Proteins
50%
Lectin Pathway Activation
50%
Half Maximal Inhibitory Concentration
50%
Cisplatin
33%
Plasmodium Falciparum
22%
Chemoresistant
22%
Sugar Chain
22%
Chondroitin Sulfate Proteoglycans
22%
In Situ
22%
Malaria Parasite
22%
Neoadjuvant Chemotherapy
22%
Biochemistry, Genetics and Molecular Biology
Complement Lectin Pathway
100%
Cisplatin
100%
Glycosaminoglycan
100%
Factor H
100%
Chondroitin Sulfate
90%
N-Terminus
42%
C-Terminus
28%
Lectin
28%
IC50
24%
Plasmodium
20%
Plasmodium falciparum
20%
Immunology and Microbiology
Alternative Complement Pathway
100%
Factor H
100%
Complement Lectin Pathway
100%
Amino Terminal Sequence
42%
Carboxy Terminal Sequence
28%
Lectin
28%
